The clinical information you need, at your fingertips.

More than 20 researchers pressure-tested widely held beliefs about dietary protein. Only a few held up; most were judged plausible but short of proof by current evidence standards. . .

In the phase 2b SOLSTICE trial, once-daily oral elecoglipron significantly improved glycemic control and reduced body weight. . .

Population-level Australian data suggest updated infant feeding guidance may be reducing egg allergy prevalence in young children. . .

Real-world data show reduced thromboembolism, ED visits, and mortality with GLP‑1 therapy. . .

Large real-world study suggests meaningful reductions in obesity-related cancers beyond weight control. . .

Dapirolizumab pegol significantly increased clinical response rates and showed steroid-sparing potential in patients with moderate-to-severe systemic lupus erythematosus. . .